BioModels
Collaborative Capabilities

Capabilities

IVIS

Optical imaging can provide essential information for a variety of pre-clinical experiments, including oncology modeling studies, biodistribution studies, and more. In vivo imaging can be a critical tool for many preclinical oncology models, providing non-invasive, quantitative data on tumor pathology and tumor growth kinetics. Additionally, both in vivo and ex vivo imaging allows for visual assessment and quantification of the biodistribution of tagged compounds of interest for pharmacokinetic and pharmacodynamic studies. BioModels has 2D imaging capabilities for the detection of either bioluminescent or fluorescent compounds. Customizable study designs allow for flexible imaging timepoints to most accurately assess your marker of interest.

Capabilities

IVIS

IVIS

Daniel Lichtman

Managing Partner